Comparison of AGA-IgM and IgG levels between GC patients and healthy donors in the 35–50 age subgroup: Given the significant age differences between the GC patient and healthy donor cohorts (see Section 4.1 in Materials and Methods), we analyzed age-matched subgroups (35–50 years) with comparable sizes. Here, CD40LG is linked to gastric cancer.